← All stocks

ARVINAS, INC.

ARVN Net selling
CIK 0001655759 #2976 in the set updated 19 Sep 2026
Bought (120 mo)
$69.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$161.24M
$66.04K on a plan · $43.80M straight out of an exercise
Sold at will
$117.37M
118 of 200 sales
Net
−$91.62M
−$47.76M against sales at will

By person

28 insiders · 240 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SHANNON TIMOTHY M
Director
$372.83K (5)
$34.51M (25)
−$34.14M
11,211,782
17.15%
$91.48M
+70.0%
5AM VENTURES III, L.P. entity
10% owner
$26.56M (8)
−$26.56M
1,002
0.0015%
$8.18K
Houston John G
Director
$480.00K (1)
$17.74M (26) scheduled
−$17.26M
1,122,183
1.72%
$9.16M
+51.1%
RA CAPITAL MANAGEMENT, L.P. entity
Former 10% Owner
$16.00M (1)
+$16.00M
3,138,412
4.80%
$25.61M
Ratcliffe Liam
Director
$40.96M (4)
$51.37M (39)
−$10.41M
1,008,543
1.54%
$8.23M
Cassidy Sean A
Chief Financial Officer
$25.60K (1)
$9.32M (26) scheduled
−$9.30M
181,916
0.2782%
$1.48M
+8.4%
Taylor Ian
President, R&D
$14.66K (1)
$7.71M (27) scheduled
−$7.69M
159,121
0.2434%
$1.30M
+88.3%
Peck Ronald
Chief Medical Officer
$5.05M (9) scheduled
−$5.05M
67,516
0.1033%
$550.86K
Flynn James E
10% owner
$5.00M (3)
+$5.00M
1,233,734
1.89%
$10.07M
Loven Jakob
Director
$5.00M (1)
+$5.00M
1,694,351
2.59%
$13.82M
Margus Bradley Albert
Director
$640.00K (1)
$5.02M (5)
−$4.38M
61,463
0.0940%
$501.48K
+3.4%
Morrison Briggs
Director
$590.53K (3)
$2.77M (7) scheduled
−$2.18M
111,548
0.1706%
$910.12K
+312.8%
Kennedy Edward Moore Jr.
Director
$535.91K (2)
+$535.91K
54,957
0.0840%
$448.39K
Berkowitz Noah
Chief Medical Officer
$323.78K (4)
−$323.78K
191,395
0.2927%
$1.56M
Cacace Angela M
Chief Scientific Officer
$303.60K (8)
−$303.60K
180,390
0.2759%
$1.47M
+375.6%
Saik Andrew
Chief Financial Officer
$261.59K (4)
−$261.59K
187,432
0.2867%
$1.53M
Teel Randy
President and CEO
$226.48K (5)
−$226.48K
285,009
0.4359%
$2.33M
+96.6%
Loomis David K
VP, Chief Accounting Officer
$77.53K (7)
−$77.53K
40,193
0.0615%
$327.93K
+622.8%
Canaan IX L.P.
10% owner
3,589,554
5.49%
$29.29M
ELM STREET VENTURES L P entity
Former 10% owner
767,623
1.17%
$6.26M
Norwalk Leslie V
Director
41,572
0.0636%
$339.19K
Cunningham Everett
Director
41,572
0.0636%
$339.19K
Smaldone Alsup Laurie
Director
41,572
0.0636%
$339.19K
Bain Linda
Director
41,572
0.0636%
$339.19K
AGARWAL SUNIL
Director
30,166
0.0461%
$246.12K
YOUNG JOHN D
Director
26,045
0.0398%
$212.50K
DIXON WENDY L
Director
9,121
0.0139%
$74.42K
+82.4%
PARMAR KUSH
Director
1,775
0.0027%
$14.48K
Insider
Date
Role
Action
Shares
Price
Amount
Taylor Ian
4 Jan 2024
Chief Scientific Officer
Exercised, kept
8,252
$16.00
$132.03K
Taylor Ian
1 Mar 2022
Chief Scientific Officer
Exercised, kept
3,500
$16.00
$56.00K
Houston John G
2 Sep 2021
President and CEO
Exercised, kept
2,462
$16.00
$39.39K
Houston John G
2 Sep 2021
President and CEO
Exercised, kept
2,228
$16.00
$35.65K
Taylor Ian
19 Feb 2021
Chief Scientific Officer
Exercised, kept
6,456
$16.00
$103.30K
Cassidy Sean A
17 Feb 2021
Chief Financial Officer
Exercised, kept
569
$16.00
$9.10K
Cassidy Sean A
17 Feb 2021
Chief Financial Officer
Exercised, kept
325
$16.00
$5.20K
Houston John G
16 Feb 2021
President and CEO
Exercised, kept
1,560
$16.00
$24.96K
Cassidy Sean A
9 Nov 2020
Chief Financial Officer
Exercised, kept
3,006
$16.00
$48.10K
SHANNON TIMOTHY M
26 May 2020
Director
Exercised, kept
12,923
$22.06
$285.08K
Ratcliffe Liam
26 May 2020
Director
Exercised, kept
6,500
$22.06
$143.39K
Cassidy Sean A
13 May 2020
Chief Financial Officer
Exercised, kept
1,356
$16.00
$21.70K
Cassidy Sean A
23 Mar 2020
Chief Financial Officer
Exercised, kept
8,030
$16.00
$128.48K
Houston John G
23 Mar 2020
President and CEO
Exercised, kept
6,250
$16.00
$100.00K
Taylor Ian
28 Jan 2020
Chief Scientific Officer
Exercised, kept
13,042
$16.00
$208.67K
Houston John G
17 Dec 2019
President and CEO
Exercised, kept
12,500
$16.00
$200.00K
Cassidy Sean A
7 Aug 2019
Chief Financial Officer
Exercised, kept
6,250
$16.00
$100.00K

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 80
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 25,802,990
Sales filed before the plan box existed 81
History held since 28 Sep 2018